| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $41.3B | $38.8B | $37.2B | $34.2B | $27.7B | $22.0B | $28.2B | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $10.8B | $10.1B | $8.4B | $7.5B | $8.1B | $1.4B | $1.7B | $2.0B |
| EPS (Basic) | $15.41 | $14.04 | $11.23 | $9.86 | $10.04 | $1.76 | $2.04 | $2.33 |
| EPS (Diluted) | $15.38 | $14.01 | $11.21 | $9.85 | $10.02 | $1.76 | $2.03 | $2.32 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $300.1B | $271.5B | $261.1B | $228.4B | $188.5B | $191.4B | $198.3B | $188.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $266.6B | $241.2B | $233.1B | $203.6B | $166.4B | $168.4B | $175.3B | $166.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $33.5B | $30.3B | $28.1B | $24.7B | $22.2B | $23.0B | $23.1B | $22.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $18.4B | $14.1B | $18.6B | $21.1B | $14.6B | $5.6B | $13.6B | — |
| Investing Cash Flow | $-22.9B | $-24.4B | $-24.4B | $-33.7B | $-10.5B | $11.6B | $-16.7B | — |
| Capital Expenditures | $2.4B | $1.9B | $1.6B | $1.9B | $1.6B | $1.5B | $1.6B | $1.3B |
| Financing Cash Flow | $11.2B | $4.4B | $18.4B | $24.5B | $-14.9B | $-9.1B | $-0.5B | — |